PROKIDNEY CORP. financial data

Symbol
PROK on Nasdaq
Location
Winston Salem, NC
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 10 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1092% % -38%
Debt-to-equity -3.5% % -31%
Return On Equity 7.1% % 61%
Return On Assets -18% % -77%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float $232,629,556 USD -66%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $119,747,000 USD 8.5%
General and Administrative Expense $52,204,000 USD 14%
Operating Income (Loss) $171,207,000 USD -9.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $155,542,000 USD -14%
Income Tax Expense (Benefit) $3,701,000 USD 654%
Net Income (Loss) Attributable to Parent $71,033,000 USD -56%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $95,323,000 USD -12%
Other Assets, Current $110,000 USD -89%
Assets, Current $299,989,000 USD -30%
Property, Plant and Equipment, Net $47,754,000 USD 24%
Operating Lease, Right-of-Use Asset $3,803,000 USD -36%
Assets $351,608,000 USD -26%
Accounts Payable, Current $1,942,000 USD -32%
Accrued Liabilities, Current $26,068,000 USD 23%
Liabilities, Current $29,063,000 USD 15%
Accrued Income Taxes, Noncurrent $962,000 USD 25%
Operating Lease, Liability, Noncurrent $3,181,000 USD -40%
Liabilities $33,270,000 USD 6.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax $74,000 USD -77%
Retained Earnings (Accumulated Deficit) $1,250,604,000 USD -6%
Stockholders' Equity Attributable to Parent $1,008,020,000 USD -2.9%
Liabilities and Equity $351,608,000 USD -26%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $29,592,000 USD 15%
Net Cash Provided by (Used in) Investing Activities $28,289,000 USD -52%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,315,000 USD -106%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $95,323,000 USD -12%
Deferred Tax Assets, Valuation Allowance $6,928,000 USD -46%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0 pure -100%
Deferred Tax Assets, Gross $7,991,000 USD -44%
Operating Lease, Liability $4,154,000 USD -34%
Depreciation $5,615,000 USD 45%
Payments to Acquire Property, Plant, and Equipment $1,135,000 USD 18%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $71,280,000 USD -58%
Lessee, Operating Lease, Liability, to be Paid $5,263,000 USD -37%
Operating Lease, Liability, Current $973,000 USD -5.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,292,000 USD -30%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,429,000 USD -15%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,109,000 USD -46%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,075,000 USD -38%
Deferred Tax Assets, Operating Loss Carryforwards $143,000 USD -51%
Unrecognized Tax Benefits $748,000 USD 32%
Lessee, Operating Lease, Liability, to be Paid, Year Four $457,000 USD -66%
Operating Lease, Payments $261,000 USD -6.5%
Additional Paid in Capital $242,480,000 USD 22%
Depreciation, Depletion and Amortization $1,600,000 USD 45%
Deferred Tax Assets, Net of Valuation Allowance $1,063,000 USD -29%
Share-based Payment Arrangement, Expense $26,581,000 USD 66%
Interest Expense $5,000 USD -50%